| 000 | 01657 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518081628.0 | ||
| 264 | 0 | _c20201021 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1083-351X | ||
| 024 | 7 |
_a10.1074/jbc.RA119.010838 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRomero, Celeste | |
| 245 | 0 | 0 |
_aA cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _c02 2020 |
||
| 300 |
_a2601-2613 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarcinogenesis _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xmetabolism |
| 650 | 0 | 4 | _aGain of Function Mutation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aProtein Tyrosine Phosphatase, Non-Receptor Type 11 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 700 | 1 | _aLambert, Lester J | |
| 700 | 1 | _aSheffler, Douglas J | |
| 700 | 1 | _aDe Backer, Laurent J S | |
| 700 | 1 | _aRaveendra-Panickar, Dhanya | |
| 700 | 1 | _aCeleridad, Maria | |
| 700 | 1 | _aGrotegut, Stefan | |
| 700 | 1 | _aRodiles, Socorro | |
| 700 | 1 | _aHolleran, John | |
| 700 | 1 | _aSergienko, Eduard | |
| 700 | 1 | _aPasquale, Elena B | |
| 700 | 1 | _aCosford, Nicholas D P | |
| 700 | 1 | _aTautz, Lutz | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 295 _gno. 9 _gp. 2601-2613 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.RA119.010838 _zAvailable from publisher's website |
| 999 |
_c30533775 _d30533775 |
||